Value
6.8/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 9.1 |
| P/S | 9.4 |
| EV/EBITDA | 7.9 |
| Fwd P/E | 9.1 |
| PEG | 4.1 |
| Analyst target | 3.0 |
- ▸Forward P/E: 11.1x
- ▸PEG: 2.36
TRV · Why this verdict
Why The Travelers Companies (TRV) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.3/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Travelers Companies has beaten earnings estimates in all 4 of the last 4 quarters with an extraordinary average surprise of 35.2%, delivers a 25% ROE with 175% free cash flow conversion, and exhibits strong technical momentum — a high-quality insurance compounder currently priced near analyst targets.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Travelers has delivered a perfect 4-for-4 earnings beat streak with an average surprise of 35.2% — including an 80% beat in the most recent summer quarter and 28% in Q3 2025 — representing unusually strong and consistent outperformance that reflects either disciplined underwriting or significant reserve releases. Earnings | Earnings beat rate remains at 100% for the next 2 quarters with average surprise staying above 15%, confirming that the outperformance is driven by structural underwriting quality rather than one-time items. | →Stable |
| CounterVery large beat percentages of 80% and 28% suggest estimates may have been set too conservatively; once analysts recalibrate to the true earnings power, future beats will be much smaller or could turn into misses. | ||
Free cash flow at 175% of net income — classified as excellent cash conversion — combined with a 25% ROE and Piotroski score of 8/9 indicates that Travelers generates substantially more cash than it reports in earnings, reflecting the quality of its insurance float and investment portfolio management. Quality breakdown | Free cash flow conversion remains above 120% of net income over the next four quarters, sustaining the quality advantage that differentiates Travelers from lower-quality insurance peers. | →Stable |
| CounterHigh free cash flow relative to net income in insurance can reflect timing of claim payments and premium receipt rather than structural superiority; catastrophe years could reverse this pattern sharply. | ||
A golden cross with RSI at 53, MACD bullish, rising on-balance volume, and above all major moving averages at a momentum score of 8.1 out of 10 — combined with volume accumulation — places Travelers in a technically strong position with institutional buying support behind the price. Momentum breakdown | Price sustains above the 200-day moving average for at least 8 consecutive months and on-balance volume continues its upward trend, confirming that the breakout is driven by genuine institutional demand. | →Stable |
| CounterAt only 2.1% below the 52-week high with the stock trading above analyst price targets, the technical breakout may be near exhaustion, with limited room for further upside before triggering profit-taking. | ||
With the stock trading above the analyst consensus price target — reflected in -8.1% analyst upside — Travelers is currently priced beyond what the professional analyst community believes is fair value, requiring either further earnings upgrades or multiple expansion to justify the current level. Warnings | Analyst consensus price targets increase by at least 10% above the current price within 12 months as the strong earnings beat streak drives upward estimate revisions that reset the target above the market price. | →Stable |
| CounterThe stock's 35% average earnings beat streak is likely to force analyst target increases quickly; the current above-target pricing may be forward-looking premium that subsequent analyst revisions will validate. | ||
Travelers has delivered a perfect 4-for-4 earnings beat streak with an average surprise of 35.2% — including an 80% beat in the most recent summer quarter and 28% in Q3 2025 — representing unusually strong and consistent outperformance that reflects either disciplined underwriting or significant reserve releases.
→StableEarnings
- Expectation
- Earnings beat rate remains at 100% for the next 2 quarters with average surprise staying above 15%, confirming that the outperformance is driven by structural underwriting quality rather than one-time items.
CounterVery large beat percentages of 80% and 28% suggest estimates may have been set too conservatively; once analysts recalibrate to the true earnings power, future beats will be much smaller or could turn into misses.
Free cash flow at 175% of net income — classified as excellent cash conversion — combined with a 25% ROE and Piotroski score of 8/9 indicates that Travelers generates substantially more cash than it reports in earnings, reflecting the quality of its insurance float and investment portfolio management.
→StableQuality breakdown
- Expectation
- Free cash flow conversion remains above 120% of net income over the next four quarters, sustaining the quality advantage that differentiates Travelers from lower-quality insurance peers.
CounterHigh free cash flow relative to net income in insurance can reflect timing of claim payments and premium receipt rather than structural superiority; catastrophe years could reverse this pattern sharply.
A golden cross with RSI at 53, MACD bullish, rising on-balance volume, and above all major moving averages at a momentum score of 8.1 out of 10 — combined with volume accumulation — places Travelers in a technically strong position with institutional buying support behind the price.
→StableMomentum breakdown
- Expectation
- Price sustains above the 200-day moving average for at least 8 consecutive months and on-balance volume continues its upward trend, confirming that the breakout is driven by genuine institutional demand.
CounterAt only 2.1% below the 52-week high with the stock trading above analyst price targets, the technical breakout may be near exhaustion, with limited room for further upside before triggering profit-taking.
With the stock trading above the analyst consensus price target — reflected in -8.1% analyst upside — Travelers is currently priced beyond what the professional analyst community believes is fair value, requiring either further earnings upgrades or multiple expansion to justify the current level.
→StableWarnings
- Expectation
- Analyst consensus price targets increase by at least 10% above the current price within 12 months as the strong earnings beat streak drives upward estimate revisions that reset the target above the market price.
CounterThe stock's 35% average earnings beat streak is likely to force analyst target increases quickly; the current above-target pricing may be forward-looking premium that subsequent analyst revisions will validate.
Per-dimension breakdown
Quality
6.2/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 8.4 |
| ROA | 3.0 |
| Gross margin | 2.6 |
| Op margin | 7.5 |
| Net margin | 7.8 |
| Current ratio | 1.3 |
| FCF quality | 10.0 |
| Moat | 6.4 |
| Piotroski F | 8.9 |
- ▸Excellent ROE: 25%
- ▸Strong margins: 16%
- ▸Excellent cash conversion: 175% FCF/NI
- ▸Strong Piotroski F-Score: 8/9
Growth
2.7/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 2.7 |
Momentum
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 3.8 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 2.2 |
- ▸Overbought (RSI 83)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
5.2/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 5.9 |
| Analyst rating | 5.0 |
| Price target | 4.6 |
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.0 |
- ▸Insider selling (low materiality) — $12,815,190 (0.019% of mkt cap)
Peer rank
3.9/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 6.2 |
| quality rank | 7.2 |
| growth rank | 2.1 |
Technical
3.5/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.6 |
| 52w position | 9.9 |
Risk (lower is worse)
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.4 |
| days to cover | 6.3 |
| volatility | 7.0 |
| put call | 2.5 |
| implied vol | 7.2 |
| beta | 10.0 |
| debt equity | 8.8 |
- ▸Elevated put/call: 1.62
Catalyst
7.2/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| dividend safety | 5.2 |
| news activity | 8.0 |
- ▸Perfect beat streak: 4Q
- ▸Dividend: 158.0%
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (6)
- MOMENTUM:7.0>=5.5
- INSIDER:OK
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:22d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-1.1=NEGATIVE
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-1.12
Upside
-12.2%
Downside
10.9%
Sizing output
AVOID
SetupUNKNOWN — No clear chart pattern; technical signals are mixed
EdgeCATALYST — Earnings in 22d with 4/4 beat streak
SuitabilityMODERATE — Balanced profile
Investment implication
The F-path SELL output reflects an overall score of 5.3 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Risk (lower is worse) at 7.2) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.1=NEGATIVE) reinforce the read. Current asymmetry R:R is -1.12 — supplementary context, not the trigger for this path.
The strongest dimensions are Risk (lower is worse) at 7.2, Catalyst at 7.2, and Momentum at 7.0; the weakest are Growth at 2.7, Technical at 3.5, and Peer rank at 3.9. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -1.12 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Travelers has delivered a perfect 4-for-4 earnings beat streak with an average surprise of 35.2% — including an 80% beat in the most recent summer quarter and 28% in Q3 2025 — representing unusually strong and consistent outperformance that reflects either disciplined underwriting or significant reserve releases.
Trip ifEPS surprise falls below 0% in at least 2 of the next 4 quarters, breaking the perfect beat streak and suggesting estimates have been reset to a level the business cannot exceed.
- P2Free cash flow at 175% of net income — classified as excellent cash conversion — combined with a 25% ROE and Piotroski score of 8/9 indicates that Travelers generates substantially more cash than it reports in earnings, reflecting the quality of its insurance float and investment portfolio management.
Trip ifFree cash flow as a percentage of net income falls below 80% for 2 or more consecutive quarters, indicating the premium cash conversion quality is not sustained.
- P3A golden cross with RSI at 53, MACD bullish, rising on-balance volume, and above all major moving averages at a momentum score of 8.1 out of 10 — combined with volume accumulation — places Travelers in a technically strong position with institutional buying support behind the price.
Trip ifPrice drops below the 200-day moving average and stays below it for more than 30 consecutive trading days, breaking the breakout momentum setup.
- P4With the stock trading above the analyst consensus price target — reflected in -8.1% analyst upside — Travelers is currently priced beyond what the professional analyst community believes is fair value, requiring either further earnings upgrades or multiple expansion to justify the current level.
Trip ifAnalyst consensus price target declines below $280.00 — more than 8% below the current $306.47 — indicating professional models are marking down rather than upgrading their view of intrinsic value.